Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
112.50
-2.76 (-2.39%)
Jan 16, 2026, 4:00 PM EST - Market closed
Revvity Market Cap
Revvity has a market cap or net worth of $12.75 billion as of January 16, 2026. Its market cap has decreased by -6.10% in one year.
Market Cap
12.75B
Enterprise Value
15.19B
1-Year Change
-6.10%
Ranking
Category
Stock Price
$112.50
Market Cap Chart
Since December 1, 1998, Revvity's market cap has increased from $1.28B to $12.75B, an increase of 894.37%. That is a compound annual growth rate of 8.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 12.75B | 16.28% |
| Dec 31, 2025 | 10.97B | -19.25% |
| Dec 31, 2024 | 13.58B | 0.69% |
| Dec 29, 2023 | 13.49B | -23.84% |
| Dec 30, 2022 | 17.71B | -30.20% |
| Dec 31, 2021 | 25.37B | 57.91% |
| Dec 31, 2020 | 16.07B | 48.95% |
| Dec 31, 2019 | 10.79B | 23.46% |
| Dec 31, 2018 | 8.74B | 8.41% |
| Dec 29, 2017 | 8.06B | 41.08% |
| Dec 30, 2016 | 5.71B | -4.73% |
| Dec 31, 2015 | 6.00B | 21.39% |
| Dec 31, 2014 | 4.94B | 6.60% |
| Dec 31, 2013 | 4.63B | 27.20% |
| Dec 31, 2012 | 3.64B | 61.08% |
| Dec 30, 2011 | 2.26B | -25.79% |
| Dec 31, 2010 | 3.05B | 26.77% |
| Dec 31, 2009 | 2.40B | 46.34% |
| Dec 31, 2008 | 1.64B | -46.73% |
| Dec 31, 2007 | 3.08B | 12.83% |
| Dec 29, 2006 | 2.73B | -11.29% |
| Dec 30, 2005 | 3.08B | 6.97% |
| Dec 31, 2004 | 2.88B | 33.04% |
| Dec 31, 2003 | 2.17B | 107.75% |
| Dec 31, 2002 | 1.04B | -70.73% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |